BVF PARTNERS L P/IL Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is a in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and a 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and a 10% Owner in Capstone Therapeutics Corp. ($CAPS) and a 10% Owner in REPLIGEN CORP ($RGEN) and a 10% Owner in AVIGEN INC \DE ($AVGN) and a 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and a 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and a 10% Owner in ARQULE INC ($ARQL) and a 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and a 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and a 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and a 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and a 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and a 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and a 10% Owner in ICAGEN INC ($ICGN) and a 10% Owner in ChemoCentryx, Inc. ($CCXI) and a 10% Owner in Celera CORP ($CRA) and a 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).

Address: 900 N. MICHIGAN AVE., SUITE 1100 CHICAGO 60611 IL

Companies in which BVF PARTNERS L P/IL is an Insider

ABBOTT BIOTHERAPEUTICS CORP

Trading Symbol: FACT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,940,070 shares
Latest Transaction: Feb 09 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARQULE INC

Trading Symbol: ARQL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,208,073 shares
Current Value: $5,765,060
Latest Transaction: Apr 07 2010
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARRAY BIOPHARMA INC

Trading Symbol: ARRY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,893,000 shares
Current Value: $51,523,290
Latest Transaction: Dec 05 2011
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Astex Pharmaceuticals, Inc

Trading Symbol: SUPG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,583,399 shares
Latest Transaction: Apr 21 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AVIGEN INC \DE

Trading Symbol: AVGN
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 7,837,189 shares
Latest Transaction: Nov 20 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Capstone Therapeutics Corp.

Trading Symbol: CAPS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,993,637 shares
Current Value: $359,427
Latest Transaction: Jul 03 2014
$CAPS Market Capitalization: $3.48M
$CAPS Previous Close: $0.09

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CATALYST BIOSCIENCES, INC.

Trading Symbol: CBIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,523,707 shares
Current Value: $898,987
Latest Transaction: Nov 19 2012
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Celera CORP

Trading Symbol: CRA
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 19,127,967 shares
Latest Transaction: May 17 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ChemoCentryx, Inc.

Trading Symbol: CCXI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 1,251,914 shares
Current Value: $8,350,266
Latest Transaction: Dec 05 2013
$CCXI Market Capitalization: $309.30M
$CCXI Previous Close: $6.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

DYNAVAX TECHNOLOGIES CORP

Trading Symbol: DVAX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,278,851 shares
Current Value: $16,901,461
Latest Transaction: Sep 11 2009
$DVAX Market Capitalization: $154.11M
$DVAX Previous Close: $3.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

EPIRUS Biopharmaceuticals, Inc.

Trading Symbol: CRXX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 6,830,972 shares
Latest Transaction: Dec 24 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ICAGEN INC

Trading Symbol: ICGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 625,400 shares
Latest Transaction: Sep 09 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

KENT INTERNATIONAL HOLDINGS INC

Trading Symbol: CRTQ
Industry: BLANK CHECKS [6770]
Position of BVF PARTNERS L P/IL:
Holdings: 0 shares
Latest Transaction: Dec 28 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LIGAND PHARMACEUTICALS INC

Trading Symbol: LGND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,008,834 shares
Current Value: $216,632,659
Latest Transaction: Nov 29 2013
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEUROBIOLOGICAL TECHNOLOGIES INC /CA/

Trading Symbol: NTII
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 331,998 shares
Current Value: $6,640
Latest Transaction: Oct 23 2009
$NTII Market Capitalization: $405285.00
$NTII Previous Close: $0.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEUROCRINE BIOSCIENCES INC

Trading Symbol: NBIX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 3,527,700 shares
Current Value: $153,807,720
Latest Transaction: Oct 14 2011
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

REPLIGEN CORP

Trading Symbol: RGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,765,050 shares
Current Value: $80,850,062
Latest Transaction: Jul 08 2009
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

RIGEL PHARMACEUTICALS INC

Trading Symbol: RIGL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 646,559 shares
Current Value: $1,584,070
Latest Transaction: Nov 20 2013
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of BVF PARTNERS L P/IL

Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 03 2014CAPSCapstone Therapeut ...BVF PARTNERS L P/IL10% OwnerSellJ0.30616,563184,9693,993,6374.6 M to 4 M (-13.37 %)
Nov 20 2013RIGLRIGEL PHARMACEUTIC ...BVF PARTNERS L P/IL10% OwnerSellS2.64153,056404,343646,559799.6 K to 646.6 K (-19.14 %)
Nov 20 2013RIGLRIGEL PHARMACEUTIC ...BVF PARTNERS L P/IL10% OwnerSellS2.64331,566875,9311,123,8481.5 M to 1.1 M (-22.78 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.07154,5788,822,4932,008,8342.2 M to 2 M (-7.15 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0727,0581,544,327101,523128.6 K to 101.5 K (-21.04 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0750,9342,907,043190,967241.9 K to 191 K (-21.06 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0786,4354,933,252324,836411.3 K to 324.8 K (-21.02 %)

View all BVF PARTNERS L P/IL insider transactions.

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

What Happens When a Company Gets Delisted?

When listed on a major exchange, such as the NYSE or Nasdaq, the companies and their stock have to meet several listing requirements on stock price, trading volume, capitalization, disclosure of material information or financial reporting. More ...

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

Contact us | Follow us on Twitter